| Revenue | SEK 43,1M | -2% |
| EBITDA | SEK 27,8M | -3% |
| Net profit | SEK 95K | +352% |
| Total assets | SEK 287,4M | +17% |
| Equity | SEK 45,6M | +0% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 86 116 | 94 297 | 45 643 | 44 109 | 43 130 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 38 014 | 53 261 | 4 145 | 28 571 | 27 774 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 38 014 | 53 261 | 4 145 | 28 571 | 27 774 |
| Net financials | −407 | 445 | −1 | 40 | 26 |
| Profit before tax | −17 | 6 | 45 | 11 | 110 |
| Tax | −3 | −6 | −7 | 10 | −15 |
| Net profit | −20 | 0 | 38 | 21 | 95 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 701 652 | 794 654 | 549 094 | 245 321 | 287 390 |
| Equity | 45 408 | 45 408 | 45 446 | 45 468 | 45 563 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 656 244 | 749 246 | 503 648 | 199 853 | 241 827 |
| Total debt | 656 244 | 749 246 | 503 648 | 199 853 | 241 827 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Auditor | Chief Auditor | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Jens Ulrik Kristian Nyström | Board of Directors | 0 companies |
| Lena Margareta Eleonora Nordin | Board of Directors | 0 companies |
| Karl Henric Gunnar Bunge | Chairman | 0 companies |